A gene-expression signature as a predictor of survival in breast cancer

New England Journal of Medicine

Volumn 347, Issue 25, 2002, Pages 1999-2009

  Van De Vijver, Marc J ^a   He, Yudong D ^c   Van 'T Veer, Laura J ^a   Dai, Hongyue ^c   Hart, Augustinus A M ^a   Voskuil, Dorien W ^a   Schreiber, George J ^c   Peterse, Johannes L ^a   Roberts, Chris ^c   Marton, Matthew J ^c   Parrish, Mark ^c   Atsma, Douwe ^a   Witteveen, Anke ^a   Glas, Annuska ^a   Delahaye, Leonie ^a   Van Der Velde, Tony ^a   Bartelink, Harry ^a   Rodenhuis, Sjoerd ^a   Rutgers, Emiel T ^a   Friend, Stephen H ^c   Bernards, Réne ^a,b   more..

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c ROSETTA INPHARMATICS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; CONFIDENCE INTERVAL; DISEASE ASSOCIATION; DNA MICROARRAY; EVALUATION; FEMALE; FOLLOW UP; GENE EXPRESSION; GENETIC ANALYSIS; HAZARD ASSESSMENT; HISTOPATHOLOGY; HORMONAL THERAPY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGE FACTORS; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PATIENT SELECTION; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL ANALYSIS;

EID: 0037137519     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa021967     Document Type: Article

References (20)

1. Early Breast Cancer Trialists' Collaborative Group. Polychemotherapy for early breast cancer: An overview of the randomised trials. Lancet 1998; 352:930-42.
2. Idem. Tamoxifen for early breast cancer: An overview of the randomised trials. Lancet 1998;351:1451-67.
3. Goldhirsch A, Glick JH, Gelber RD, Coates AS, Senn HJ. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer: Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 2001;19:3817-27.
4. Eifel P, Axelson JA, Costa J, et al. National Institutes of Health Consensus Development Conference Statement: Adjuvant therapy for breast cancer, November 1-3, 2000. J Natl Cancer Inst 2001;93:979-89.
5. Isaacs C, Stearns V, Hayes DF. New prognostic factors for breast cancer recurrence. Semin Oncol 2001;28:53-67.
6. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature 2000;406:747-52.
7. Sorlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001;98:10869-74.
8. Hedenfalk I, Duggan D, Chen Y, et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med 2001;344:539-48.
9. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-6.
10. Gruvberger S, Ringner M, Chen Y, et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 2001;61:5979-84.
11. West M, Blanchette C, Dressman H, et al. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci U S A 2001;98:11462-7.
12. Ahr A, Karn T, Solbach C, et al. Identification of high risk breast-cancer patients by gene expression profiling. Lancet 2002;359:131-2.
13. Elston CW, Ellis IO. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up. Histopathology 1991;19:403-10.
14. Hughes TR, Mao M, Jones AR, et al. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nat Biotechnol 2001;19:342-7.
15. Klein JP. Small sample moments of the estimators of the variance of the Kaplan-Meier and Nelson-Aalen estimators. Scand J Stat 1991;18:333-40.
16. Cox DR. Regression models and life-tables. J R Stat Soc [B] 1972;34: 187-220.
17. Lin DY, Wei LJ. The robust inference for the Cox proportional hazards model. J Am Stat Assoc 1989;84:1074-8.
18. Therneau TM, Grambsch PM, Fleming TR. Martingale-based residuals for survival models. Biometrika 1990;77:147-60.
19. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994;81:515-26.
20. Bernards R, Weinberg RA. A progression puzzle. Nature 2002;418: 823.